Synthesis, Characterization, and Biological Evaluation of M(I)(CO)3(NNO) Complexes (M = Re, 99mTc) Conjugated to 2-(4-Aminophenyl)benzothiazole as Potential Breast Cancer Radiopharmaceuticals
Journal of Medicinal Chemistry2006Vol. 49(18), pp. 5408–5410
Citations Over TimeTop 12% of 2006 papers
Stamatia Tzanopoulou, Ioannis Pirmettis, G. P. Patsis, Maria Paravatou‐Petsotas, Evangelia Livaniou, Minas Papadopoulos, Maria Pelecanou
Abstract
The synthesis and biological evaluation of new M(I)(CO)3(NNO) (M = Re, 99mTc) complexes attached to the antitumor agent 2-(4-aminophenyl)benzothiazole are reported. The fluorescent rhenium complex enters MCF-7 breast cancer cells but does not enter normal HFFF-2 and MRC-5 cells. The analogous radioactive 99mTc complex produces fast blood and soft tissue clearance when administered to healthy mice. These complexes are promising candidates for developing radiopharmaceuticals for imaging (99mTc) and targeted radiotherapy (186Re, 188Re) of breast cancer.
Related Papers
- → Amperometric determination of 2-benzothiazole sulphenamide accelerators(1980)3 cited
- → Pyrazolobenzothiazoles and their conversion to cyanine dyes(1969)1 cited
- The Synthesis of Benzothiazole Derivate and Its Nature of Mould Proofing(2009)
- Group-Based Qsar on Benzothiazole Derivatives For Development of Potent Anti-Cancer Compounds:(TJPS-2019-0123.R1)(2016)
- → Synthesis, Spectral Studies and Theoretical Treatment of New Au (III) and Cu(II) Complexes of Bidenetate Ligands 2-Benzamido Benzothiazole, and 2-Actamido Benzothiazole.(2012)